Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
CPT: Pharmacometrics & Systems Pharmacology|May 15, 2025
Establishing the Exposure-QT Relationship During Bedaquiline Treatment Using a Time-Varying Tuberculosis-Specific Correction Factor (QTcTBT)Thanakorn Vongjarudech, Anne-Gaëlle Dosne, Bart Remmerie, et al.
Innovations in Clinical Neuroscience|September 17, 2011
A Post-hoc comparison of paliperidone palmitate to oral risperidone during initiation of long-acting risperidone injection in patients with acute schizophreniaSrihari Gopal, Gahan Pandina, Rosanne Lane, et al.
Journal of Affective Disorders|October 16, 2010
Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled studyJoris Berwaerts, Rosanne Lane, Isaac F Nuamah, et al.
Neuropsychiatric Disease and Treatment|June 1, 2013
Expansion of guidance for the day 8 initiation dose of paliperidone palmitate to avoid a missed doseMahesh N Samtani, Isaac Nuamah, Srihari Gopal, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 25, 2010
A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophreniaGahan Pandina, Rosanne Lane, Srihari Gopal, et al.
Clinical Pharmacology : Advances and Applications|August 14, 2012
Management of antipsychotic treatment discontinuation and interruptions using model-based simulationsMahesh N Samtani, John J Sheehan, Dong-Jing Fu, et al.
Clinical Pharmacology in Drug Development|December 27, 2019
Population Pharmacokinetics of Paliperidone Palmitate (Once-Monthly Formulation) in Japanese, Korean, and Taiwanese Patients With SchizophreniaHiroko Shimizu, Martine Neyens, Marc De Meulder, et al.
British Journal of Clinical Pharmacology|June 18, 2024
Application of immunocapture and nanoflow LC-MS/MS to overcome the barriers to the quantitation of oxytocin in plasma of women in third stage labourSebastiaan Bijttebier, Tri-Hung Nguyen, Michelle P McIntosh, et al.
The International Journal of Neuropsychopharmacology|February 16, 2005
Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta) in patients with schizophreniaOla Gefvert, Bo Eriksson, Per Persson, et al.
The International Journal of Neuropsychopharmacology|July 23, 2011
A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophreniaW Wolfgang Fleischhacker, Srihari Gopal, Rosanne Lane, et al.
Pageof 4